Israel FemTech market is advancing rapidly through integrated digital health infrastructure, strong startup momentum, and targeted government and private investment. The industry addresses womens health needs across fertility, menstruation, menopause, chronic conditions, and mental wellness with personalized, accessible, and innovation-driven solutions.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Israel FemTech Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Israel FemTech Market Revenue and Volume, by Type
8.1.1 Devices
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Software
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Services
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Consumer products
8.1.4.1. Market Revenue and Volume Forecast
9.1. Israel FemTech Market Revenue and Volume, by Application
9.1.1. Pregnancy and nursing care
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Reproductive health & contraception
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Menstrual health
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. General health
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Pelvic & uterine health
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Womens wellness
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Menopause care
9.1.7.1. Market Revenue and Volume Forecast
9.1.8. Longevity & mental health
9.1.8.1. Market Revenue and Volume Forecast
10.1. Israel FemTech Market Revenue and Volume, by End Use
10.1.1. Direct-to-consumer
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Hospitals
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Surgical centers
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Fertility clinics
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Diagnostic centers
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type
11.2.2. Market Revenue and Volume Forecast, by Application
11.2.3. Market Revenue and Volume Forecast, by End Use
12.1. MobileODT
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. ThermoMind
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Shela
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Livia
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. OCON Healthcare
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Identify Genetics
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client